JPMorganChase
The Product Portfolio Operations Manager orchestrates change across Consumer Bank’s product portfolio, partnering with leaders to drive business value and adoption. This role mobilizes product teams to deliver initiatives at scale, ensuring efficient operating models and process improvements through automation and AI. The position serves as the central point of contact for the change agenda, advancing the future-state operating model while reducing change fatigue and accelerating adoption.
JPMorgan Chase is a leading global financial services firm that provides a full range of banking, investment banking, asset and wealth management, and payments and treasury services to consumers, businesses, governments, and institutions. Its consumer business operates under the Chase brand, offering retail banking, credit cards, mortgages and auto loans, while J.P. Morgan delivers corporate & investment banking, markets, securities services and asset management. Headquartered in New York, the firm combines scale, technology and risk management to serve clients worldwide. It is one of the largest banks by assets and is widely recognized for its capital markets expertise and integrated financial solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for JPMorganChase.
JPMorganChase didn’t post a salary, so this is our estimate from similar listings.
35% above the average for this role
Product Portfolio Operations Manager
JPMC
Change Enablement & Adoption Manager
AstraZeneca
Associate Director, Strategic Adoption (Change Enablement)
Parexel
Organizational Change Management Lead
M&T Bank
Senior Manager – Change Management & Adoption
oraclecloudinfrastructure
Director, Procurement Excellence
Bristol Myers Squibb